WebHighTide Therapeutics Inc. is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional therapies for metabolic and digestive diseases with significant unmet medical needs. Pipeline - HighTide Therapeutics About Us - HighTide Therapeutics ROCKVILLE, MD and SHENZHEN, CHINA, March 16, 2024— HighTide Therapeutics … ROCKVILLE, MD and SHENZHEN, CHINA, March 16, 2024— HighTide Therapeutics … Careers - HighTide Therapeutics 11140 Rockville Pike, Suite 100-551 Rockville MD 20852-3149. … WebOct 28, 2024 · HighTide Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutics for chronic gastrointestinal, metabolic, and CNS disorders, with a focus on areas of high unmet medical need and lack of effective treatment options.
HighTide Therapeutics Raises $107 Million in Series C/C
WebJan 5, 2024 · HighTide is a globally integrated clinical-stage biopharmaceutical company focusing on the discovery and development of novel multifunctional therapies for … WebApr 13, 2024 · High Tide Inc. (NASDAQ:HITI) announced its quarterly earnings results on Monday, January, 30th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The company had revenue of $81.32 million for the quarter, compared to analysts' expectations of $75.81 … how does lidar work youtube
High Tide Inc. The Rising Tide of Cannabis
WebJan 1, 2024 · HighTide Therapeutics Comparisons Description Primary Industry HQ Location Employees Total Raised Post Valuation Last Financing Details Developer and researcher … WebJan 11, 2024 · About HighTide Therapeutics ... This makes it worthwhile to examine what the stock has in store. 6h ago. TipRanks ‘Too Cheap to Ignore’: Cathie Wood Snaps Up These 2 Stocks Under $5. WebJan 5, 2024 · ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2024 - (ACN Newswire) - HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the closing of a $107 million Series C/C+ financing … how does lidocaine work on sodium channels